Cargando…

Correction: Interleukin-6: a new therapeutic target

Detalles Bibliográficos
Autores principales:	Smolen, Josef S, Maini, Ravinder N
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794500/ http://dx.doi.org/10.1186/ar2065

Ejemplares similares

Interleukin-6: a new therapeutic target
por: Smolen, Josef S, et al.
Publicado: (2006)

Correction: Historical overview of the interleukin-6 family cytokine
por: Kang, Sujin, et al.
Publicado: (2020)

Correction to: Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

Interleukin-6: a new therapeutic target in systemic sclerosis?
por: O'Reilly, Steven, et al.
Publicado: (2013)

Correction to: Mutant glucocorticoid receptor binding elements on the interleukin-6 promoter regulate dexamethasone effects
por: Chang, Wen-Teng, et al.
Publicado: (2021)

Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers
por: Ge, Yuanlong, et al.
Publicado: (2019)

Correction to: Therapeutic novelties in migraine: new drugs, new hope?
por: Do, Thien Phu, et al.
Publicado: (2019)

Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2020)

Correction: New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
Publicado: (2023)

Correction: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
Publicado: (2021)

Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
Publicado: (2023)

Correction: Squalene Synthase As a Target for Chagas Disease Therapeutics
Publicado: (2014)

Current and new antitumor necrosis factor agents in perspective
por: Maini, Ravinder N
Publicado: (2004)

Correction to: Melatonin and urological cancers: a new therapeutic approach
por: Pourhanifeh, Mohammad Hossein, et al.
Publicado: (2020)

Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
por: Odeniyide, Patience, et al.
Publicado: (2022)

Correction to: Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis
por: Choi, Changmin, et al.
Publicado: (2020)

Correction to: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’
por: Kow, Chia Siang, et al.
Publicado: (2023)

Correction to: Rilonacept (Interleukin‑1 Inhibition) for the Treatment of Pericarditis
por: Wang, Tom Kai Ming, et al.
Publicado: (2022)

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2009)

Correction to: Potential therapeutic targets for sarcopenia identified by Mendelian randomisation
Publicado: (2023)

Correction: Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
Publicado: (2020)

Correction: LRG1 as a novel therapeutic target in eye disease
por: De Rossi, Giulia, et al.
Publicado: (2022)

Interleukin-6 as a therapeutic target in locomotor disorders
por: Nishimoto, Norihiro, et al.
Publicado: (2012)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
por: Hama, Naoki, et al.
Publicado: (2022)

Correction: In Vivo Screening for Secreted Proteins That Modulate Glucose Handling Identifies Interleukin-6 Family Members as Potent Hypoglycemic Agents
por: Chen, Chen Amy, et al.
Publicado: (2012)

Combined depletion of interleukin-1 and interleukin-6 does not exceed single depletion of interleukin -1 in TNF-mediated arthritis
por: Hayer, Silvia, et al.
Publicado: (2012)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Publicado: (2015)

Correction: Modulation of Host Angiogenesis as a Microbial Survival Strategy and Therapeutic Target
por: Osherov, Nir, et al.
Publicado: (2016)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2020)

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
por: Gao, Mei, et al.
Publicado: (2020)

Correction: Parkin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration
por: Zhang, Zengjie, et al.
Publicado: (2021)

Correction: Identification and Characterization of New Molecular Partners for the Protein Arginine Methyltransferase 6 (PRMT6)
por: Lo Sardo, Alessandra, et al.
Publicado: (2013)

Correction: Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic Targets
por: Whitaker, John W., et al.
Publicado: (2015)

Correction to: Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
por: Hong, Derek, et al.
Publicado: (2023)

Author Correction: Circulating Interleukin‑6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistula
por: Hakki, Seran, et al.
Publicado: (2022)

Author Correction: Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistula
por: Hakki, Seran, et al.
Publicado: (2023)

Correction: Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer
por: Espinosa, Ana María, et al.
Publicado: (2013)

Correction: Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g1e1rctkijklcfpnvc2dvpb5gf